XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel
· Delayed Price · Currency is ILS · Price in ILA 3.000
0.00 (0.00%)
Dec 4, 2025, 4:41 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 26.44 million as of December 5, 2025. Its market cap has decreased by -67.57% in one year.
Market Cap
26.44M
Enterprise Value
22.78M
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 26.44M, a decrease of -96.72%. That is a compound annual growth rate of -15.51%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 100.49B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.12B |
| SofWave Medical | 1.03B |
| Bait Bakfar | 1.03B |
| Ilex Medical | 706.86M |
| Novolog (Pharm-Up 1966) | 664.14M |